
GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals
Keywords: CNS، سیستم عصبی مرکزی; AD, Alzheimer's disease; CNS, central nervous system; FDA, Food and Drug Administration; GSK3, glycogen synthase kinase-3; HDL, High density lipoprotein; ir, immunoreactivity; Inhibitor 1, also known as 4-Benzyl-2-methyl-1, 2,4-thiadiazolidine-3,5-dione o